Continued revenue decline and widening losses keep OSUR under near-term pressure. Monitor Q2 results for revenue stabilization and upcoming FDA decisions (CT/NG self-test, Colli-Pee) for potential catalysts.
Price Chart
Executive Summary
OraSure reported Q1 2026 revenue of $27.9M, down 7% YoY, and a GAAP EPS loss of $0.32, wider than the prior year's $0.21 loss. Gross margin improved to 42.3%, and core business (ex-COVID) was nearly flat, but operating losses grew to $23.3M. Q2 guidance of $27M-$30M revenue signals continued stabilization but no near-term profitability.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $27.9M (-7% YoY)
- GAAP EPS -$0.32 vs -$0.21 YoY
- Gross margin 42.3% vs 41.1% YoY
- Operating loss $23.3M vs $17.8M YoY
- Cash & equivalents $177M; repurchased $5M in stock
- Q2 2026 revenue guidance $27M-$30M
Financial Impact
Revenue declined 7% YoY to $27.9M; net loss widened 40% to $22.4M
Risk Factors
- Sustained top-line contraction
- Cash burn rate despite $177M cash
- Regulatory/approval delays for pipeline products
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001116463-26-000037 |
| Exhibit: ex992_q1-26investorupdat.htm | 0001116463-26-000037 |
| Document: osur-20260506.htm | 0001116463-26-000037 |
| Document: 0001116463-26-000037-index-headers.html | 0001116463-26-000037 |
| Document: 0001116463-26-000037-index.html | 0001116463-26-000037 |
| Document: 0001116463-26-000037.txt | 0001116463-26-000037 |
| 8-K Data (Synthetic) | 0001116463-26-000037 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 23, 2026 10w ago | Court Ruling | $4.03 $3.74 | ▼ −7.20% | ▼ −10.50% | $3.99 (−0.99%) |
Jun 12, 2026 16w ago | Institutional Cluster | $4.18 $4.30 | ▲ +2.75% | ▲ +0.97% | $3.99 (−4.55%) |
Jun 3, 2026 17w ago | 8-K | $4.17 $4.35 | ▲ +4.32% | ▲ +5.69% | $3.99 (−4.32%) |
May 6, 2026 21w ago | 8-K | $3.13 $3.95 | ▼ −26.20% | ▼ −23.06% | $3.99 (−27.48%) |
Apr 22, 2026 23w ago | Press Release | $3.05 $3.07 | ▼ −0.66% | ▲ +3.98% | $3.99 (−30.82%) |
Apr 17, 2026 24w ago | DEFA14A | $3.16 $2.95 | ▼ −6.65% | ▼ −12.02% | $3.99 (+26.27%) |
Apr 17, 2026 24w ago | DEFA14A | $3.16 $2.95 | ▼ −6.65% | ▼ −12.02% | $3.99 (+26.27%) |
Apr 17, 2026 24w ago | 8-K | $3.16 $2.95 | ▼ −6.65% | ▼ −12.02% | $3.99 (+26.27%) |
Mar 20, 2026 28w ago | Insider Cluster | $2.95 $3.00 | ▲ +1.53% | ▼ −7.79% | $3.99 (+35.25%) |
Mar 17, 2026 28w ago | DEFA14A | $2.90 $3.21 | ▲ +10.69% | ▲ +4.64% | $3.99 (+37.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access